Germany's Fresenius, US-based Akorn at odds over merger deal

Germany's Fresenius, US-based Akorn at odds over merger deal



Germany's Fresenius and U.S.-based pharmaceutical manufacturer Akorn Inc. are at odds over the German company's decision to terminate a more than $4.3 billion takeover agreement, citing alleged breaches of data integrity requirements.